Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve 4,5-dihydropyrazole synthesis challenges with this anhydrous-free, scalable method. Reduce costs, eliminate oxygen-sensitive equipment, and ensure consistent supply for your drug development projects.
Discover a cost-effective buparvaquone synthesis method with 68% yield and 99.9% purity. Avoid silver nitrate, reduce wastewater, and ensure supply chain stability for bovine disease treatment.
Discover a metal-free, air-stable C2-phosphono indole synthesis method with >99% purity, high atom economy, and scalable production for pharmaceutical applications.
Discover how iron-catalyzed cyclopropyl borate synthesis reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable production.
Solve metal residue issues in thioether synthesis with this metal-free, room-temperature method. Achieve 80-93% yields for drug intermediates with no expensive catalysts.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Solve N-aryl imine allylation challenges with this metal-free, air-tolerant process. Achieve 94% yields and eliminate expensive anhydrous equipment. Contact for CDMO scale-up.
Solve N-aryl imine allylation challenges with this metal-free, air-stable method. Achieve 85-94% yields at room temperature, reducing equipment costs and supply chain risks for API synthesis.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.
Solve low-yield & heavy metal issues in ramipril intermediate production. 85-99% purity, 85-99% yield, eco-friendly process. Scale to 100 MT/yr with CDMO expertise.
Solve OAB drug supply chain risks with 4-step metal-free synthesis. 95% yield, no phosphine waste. Reduce production costs by 30%.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Solve high-cost synthesis challenges for 5-trifluoromethyl-1,2,4-triazole compounds. Our metal-free, scalable method reduces catalyst costs and supply chain risks for GlyT1 inhibitors.
Discover metal-free synthesis of tetrahydrofuran-quinoline compounds with 65% yield. Eliminate catalyst costs and supply chain risks for pharmaceutical intermediates.
Solve supply chain risks with this metal-free, high-yield synthesis method for pharmaceutical intermediates. Eliminate heavy metal catalysts and reduce production costs by 30%.
Solve supply chain risks with air-atmosphere, metal-free synthesis of trifluoroacetimide-substituted dihydrobenzofuran. High stereoselectivity, low-cost raw materials, and scalable to gram level for pharma R&D and production.
Solve supply chain risks with 85-93% yield 2-hydroxyphenyl sulfide synthesis. CDMO expertise in metal-free catalysis for API manufacturing.
Solve nitrile synthesis challenges with this novel metal-free route. Achieve 78% yield, no toxic byproducts, and scalable production for anti-inflammatory drug development.
Solve C3-functionalization challenges in quinoxalinone synthesis with metal-free, visible-light catalysis. Achieve 85% yields, room-temperature operation, and no expensive equipment. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.